BRIEF published on 02/13/2025 at 22:00, 11 months 22 days ago Integrated BioPharma Reports Quarterly Results with Increased Revenue Revenue Growth Q4 Results Operating Income Customer Base Expansion Integrated BioPharma
PRESS RELEASE published on 02/13/2025 at 21:55, 11 months 22 days ago Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 Integrated BioPharma, Inc. reports 9.6% increase in revenue to $12.6 million for quarter ended Dec 31, 2024. Operating income of $0.2 million. Detailed financial results provided Financial Results Revenue Increase Quarterly Report Operating Income Integrated BioPharma
BRIEF published on 11/13/2024 at 23:38, 1 year 2 months ago Integrated BioPharma, Inc. annonce ses résultats financiers du troisième trimestre 2024 Croissance Des Revenus Revenu Net Résultats Du 3ème Trimestre 2024 Biopharmacie Intégrée Diversification De La Clientèle
BRIEF published on 11/13/2024 at 23:38, 1 year 2 months ago Integrated BioPharma, Inc. Announces Q3 2024 Financial Results Revenue Growth Net Income Integrated BioPharma Customer Diversification Q3 2024 Results
PRESS RELEASE published on 11/13/2024 at 23:33, 1 year 2 months ago Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 Integrated BioPharma, Inc. reports revenue growth in Q3 2024 with net income of $0.3 million. Diversification of customer base leads to increased financial performance Revenue Growth Financial Performance Diversification Q3 2024 Integrated BioPharma
BRIEF published on 09/20/2024 at 23:45, 1 year 4 months ago Integrated BioPharma annonce ses résultats financiers pour le trimestre et l'exercice clos le 30 juin 2024 Résultats Financiers Résultat D'exploitation Revenu Net Revenu Biopharmacie Intégrée
BRIEF published on 09/20/2024 at 23:45, 1 year 4 months ago Integrated BioPharma Announces Financial Results for Quarter and Fiscal Year Ended June 30, 2024 Financial Results Revenue Net Income Operating Income Integrated BioPharma
PRESS RELEASE published on 09/20/2024 at 23:40, 1 year 4 months ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 Integrated BioPharma, Inc. reports financial results with minor revenue decrease. Emphasis on core businesses for growth and diversification of customer base Financial Results Revenue Decrease Customer Base Integrated BioPharma Core Businesses
BRIEF published on 05/10/2024 at 22:35, 1 year 8 months ago Integrated BioPharma publie ses résultats financiers pour le premier trimestre 2024 Résultats Financiers Rapport Trimestriel Résultat D'exploitation Stabilité Des Revenus BioPharma Intégrée
BRIEF published on 05/10/2024 at 22:35, 1 year 8 months ago Integrated BioPharma Releases Financial Results for Q1 2024 Financial Results Quarterly Report Operating Income Revenue Stability Integrated BioPharma
Published on 02/08/2026 at 21:00, 14 minutes ago Banyan Gold Extends Airstrip and High-Grade Mineralization to 350m Vertical Depth, Yukon, Canada
Published on 02/07/2026 at 01:00, 1 day 20 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 22 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 23 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 2 days 5 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/07/2026 at 21:00, 1 day ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 1 day 4 hours ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 1 day 4 hours ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 2 days 1 hour ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 2 days 3 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 2 days 2 hours ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 2 days 2 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 5 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 2 days 5 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 2 days 13 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
